These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 1464010)
1. Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors. Santana VM; Schell MJ; Williams R; Bowman LC; Thompson EI; Brenner MK; Mirro J Bone Marrow Transplant; 1992 Nov; 10(5):457-62. PubMed ID: 1464010 [TBL] [Abstract][Full Text] [Related]
2. Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors. Marina NM; Rodman J; Shema SJ; Bowman LC; Douglass E; Furman W; Santana VM; Hudson M; Wilimas J; Meyer W J Clin Oncol; 1993 Mar; 11(3):554-60. PubMed ID: 8445431 [TBL] [Abstract][Full Text] [Related]
3. A dose-escalation study of carboplatin/cyclophosphamide/etoposide along with autologous bone marrow or peripheral blood stem cell rescue. Shea TC; Storniolo AM; Mason JR; Newton B; Mullen M; Taetle R; Green MR Semin Oncol; 1992 Feb; 19(1 Suppl 2):139-44. PubMed ID: 1411625 [TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study. Kleiner S; Kirsch A; Schwaner I; Kingreen D; Schwella N; Huhn D; Siegert W Bone Marrow Transplant; 1997 Dec; 20(11):953-9. PubMed ID: 9422474 [TBL] [Abstract][Full Text] [Related]
5. Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors. Broun ER; Nichols CR; Mandanas R; Salzman D; Turns M; Hromas R; Cornetta K; Einhorn LH Bone Marrow Transplant; 1995 Sep; 16(3):353-8. PubMed ID: 8535306 [TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial. Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336 [TBL] [Abstract][Full Text] [Related]
7. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma. Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343 [TBL] [Abstract][Full Text] [Related]
8. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer. Strauss GM; Lynch TJ; Elias AD; Jacobs C; Kwiatkowski DJ; Shulman LN; Carey RW; Grossbard ML; Jauss S; Sugarbaker DJ Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029 [TBL] [Abstract][Full Text] [Related]
9. Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. Nichols CR; Tricot G; Williams SD; van Besien K; Loehrer PJ; Roth BJ; Akard L; Hoffman R; Goulet R; Wolff SN J Clin Oncol; 1989 Jul; 7(7):932-9. PubMed ID: 2544687 [TBL] [Abstract][Full Text] [Related]
10. Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumors. Thiery-Vuillemin A; Dobi E; Nguyen T; Royer B; Montange D; Maurina T; Kalbacher E; Bazan F; Villanueva C; Demarchi M; Chaigneau L; Ivanaj A; Pivot X Anticancer Drugs; 2010 Nov; 21(10):958-62. PubMed ID: 20856105 [TBL] [Abstract][Full Text] [Related]
11. Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumors. Wilson WH; Jain V; Bryant G; Cowan KH; Carter C; Cottler-Fox M; Goldspiel B; Steinberg SM; Longo DL; Wittes RE J Clin Oncol; 1992 Nov; 10(11):1712-22. PubMed ID: 1403054 [TBL] [Abstract][Full Text] [Related]
12. Phase I/II study of cyclophosphamide, carboplatin, and etoposide and autologous hematopoietic stem-cell transplantation with posttransplant interferon alfa-2b for patients with lymphoma and Hodgkin's disease. Schenkein DP; Dixon P; Desforges JF; Berkman E; Erban JK; Ascensao JL; Miller KB J Clin Oncol; 1994 Nov; 12(11):2423-31. PubMed ID: 7964959 [TBL] [Abstract][Full Text] [Related]
13. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma. Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091 [TBL] [Abstract][Full Text] [Related]